Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.AuthorsRodrigues, Heloisa; Ke, Danxia; Lim, JoAnn; Stephen, Bettzy; Bellido, Jorge; Janku, Filip; Zinner, Ralph; Tsimberidou, Apostolia; Hong, David; Piha-Paul, Sarina; Fu, Siqing; Naing, Aung; Subbiah, Vivek; Karp, Daniel; Falchook, Gerald; Kurzrock, Razelle; Wheler, JenniferPublicationInvestigational New Drugs, 2015, Vol 33, Issue 3, p700ISSN0167-6997Publication typeArticleDOI10.1007/s10637-015-0238-2